HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)

NCT06978296 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic Disease
Oligometastatic Prostate Cancer (OMPC)

Interventions

RADIATION: Stereotactic body radiotherapy (SBRT)

Sponsor

Institut Cancerologie de l'Ouest